Citryll Bv
Clinical trials sponsored by Citryll Bv, explained in plain language.
-
New hope for arthritis sufferers? CIT-013 drug trial begins
Disease control Recruiting nowThis study tests a new drug called CIT-013 in 88 adults with moderately active rheumatoid arthritis. Participants will receive either CIT-013 or a placebo every two weeks for six weeks. The goal is to see if CIT-013 reduces joint swelling and pain better than a placebo, and to ch…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for painful skin condition: experimental drug CIT-013 enters Mid-Stage trial
Symptom relief Recruiting nowThis study tests whether a new drug called CIT-013 can reduce symptoms of hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 96 adults with moderate to severe HS will receive either 50 mg, 100 mg, or a placebo every two weeks for 12 weeks. Researchers…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New imaging study tracks experimental arthritis drug inside the body
Knowledge-focused Recruiting nowThis study uses special PET scans to track where an experimental drug called CIT-013 goes in the body of people with rheumatoid arthritis. The drug aims to calm inflammation caused by immune cell traps. About 12 people aged 60-85 will receive a radioactive version of the drug and…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC